APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Propofol Emulsion Injection

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Propofol Emulsion Injection Market Outlook and Growth Opportunities 2026

Report ID 17402913042 January 2026193 pages

Choose your research edition.

Industry ResearchPropofol Emulsion Injection Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Propofol Emulsion Injection Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Propofol Emulsion Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Propofol Emulsion Injection Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Propofol Emulsion Injection Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Propofol Emulsion Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Propofol Emulsion Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Propofol Emulsion Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Propofol Emulsion Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Propofol Emulsion Injection market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Propofol Emulsion Injection market include Xian Libang Pharmaceutical, Teva, Sandoz, Jiangsu Nhwa Group, Pfizer, Sinopharm Guorui Pharm, Guangdong Jiabo Pharmaceutical, Fresenius Kabi and Baxter, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Propofol Emulsion Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Propofol Emulsion Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Propofol Emulsion Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Propofol Emulsion Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Propofol Emulsion Injection Segment by Company

Xian Libang Pharmaceutical

Teva

Sandoz

Jiangsu Nhwa Group

Pfizer

Sinopharm Guorui Pharm

Guangdong Jiabo Pharmaceutical

Fresenius Kabi

Baxter

AstraZeneca

Sagent

Dr. Reddy's

B Braun

Propofol Emulsion Injection Segment by Type

20ml/vial

50ml/vial

100ml/vial

Propofol Emulsion Injection Segment by Application

Hospital

Clinics

Recovery Center

Propofol Emulsion Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Propofol Emulsion Injection status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Propofol Emulsion Injection market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Propofol Emulsion Injection significant trends, drivers, influence factors in global and regions.

6. To analyze Propofol Emulsion Injection competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Propofol Emulsion Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Propofol Emulsion Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Propofol Emulsion Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Propofol Emulsion Injection market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Propofol Emulsion Injection industry.

Chapter 3: Detailed analysis of Propofol Emulsion Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Propofol Emulsion Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Propofol Emulsion Injection in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Propofol Emulsion Injection Industry Trends Table 2. Propofol Emulsion Injection Industry Drivers Table 3. Propofol Emulsion Injection Industry Opportunities and Challenges Table 4. Propofol Emulsion Injection Industry Restraints Table 5. Global Propofol Emulsion Injection Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Propofol Emulsion Injection Revenue Share by Company (2021-2026) Table 7. Global Propofol Emulsion Injection Sales Volume by Company (W Units) & (2021-2026) Table 8. Global Propofol Emulsion Injection Sales Volume Share by Company (2021-2026) Table 9. Global Propofol Emulsion Injection Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Propofol Emulsion Injection Company Ranking, (2024-2026) & (USD Million) Table 11. Global Propofol Emulsion Injection Key Company Manufacturing Base & Headquarters Table 12. Global Propofol Emulsion Injection Company, Product Type & Application Table 13. Global Propofol Emulsion Injection Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Propofol Emulsion Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 20ml/vial Table 18. Significant Companies of 50ml/vial Table 19. Significant Companies of 100ml/vial Table 20. Global Propofol Emulsion Injection Sales Volume by Type 2021 VS 2025 VS 2032 (W Units) Table 21. Global Propofol Emulsion Injection Sales Volume by Type (2021-2026) & (W Units) Table 22. Global Propofol Emulsion Injection Sales Volume by Type (2027-2032) & (W Units) Table 23. Global Propofol Emulsion Injection Sales Volume Share by Type (2021-2026) Table 24. Global Propofol Emulsion Injection Sales Volume Share by Type (2027-2032) Table 25. Global Propofol Emulsion Injection Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Propofol Emulsion Injection Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Propofol Emulsion Injection Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Propofol Emulsion Injection Sales Value Share by Type (2021-2026) Table 29. Global Propofol Emulsion Injection Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Hospital Table 31. Significant Companies of Clinics Table 32. Significant Companies of Recovery Center Table 33. Global Propofol Emulsion Injection Sales Volume by Application 2021 VS 2025 VS 2032 (W Units) Table 34. Global Propofol Emulsion Injection Sales Volume by Application (2021-2026) & (W Units) Table 35. Global Propofol Emulsion Injection Sales Volume by Application (2027-2032) & (W Units) Table 36. Global Propofol Emulsion Injection Sales Volume Share by Application (2021-2026) Table 37. Global Propofol Emulsion Injection Sales Volume Share by Application (2027-2032) Table 38. Global Propofol Emulsion Injection Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Propofol Emulsion Injection Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Propofol Emulsion Injection Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Propofol Emulsion Injection Sales Value Share by Application (2021-2026) Table 42. Global Propofol Emulsion Injection Sales Value Share by Application (2027-2032) Table 43. Global Propofol Emulsion Injection Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 44. Global Propofol Emulsion Injection Sales by Region (2021-2026) & (W Units) Table 45. Global Propofol Emulsion Injection Sales Market Share by Region (2021-2026) Table 46. Global Propofol Emulsion Injection Sales by Region (2027-2032) & (W Units) Table 47. Global Propofol Emulsion Injection Sales Market Share by Region (2027-2032) Table 48. Global Propofol Emulsion Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Propofol Emulsion Injection Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Propofol Emulsion Injection Sales Value Share by Region (2021-2026) Table 51. Global Propofol Emulsion Injection Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Propofol Emulsion Injection Sales Value Share by Region (2027-2032) Table 53. Global Propofol Emulsion Injection Market Average Price (US$/Unit) by Region (2021-2026) Table 54. Global Propofol Emulsion Injection Market Average Price (US$/Unit) by Region (2027-2032) Table 55. Global Propofol Emulsion Injection Sales by Country: 2021 VS 2025 VS 2032 (W Units) Table 56. Global Propofol Emulsion Injection Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Propofol Emulsion Injection Sales by Country (2021-2026) & (W Units) Table 58. Global Propofol Emulsion Injection Sales Market Share by Country (2021-2026) Table 59. Global Propofol Emulsion Injection Sales by Country (2027-2032) & (W Units) Table 60. Global Propofol Emulsion Injection Sales Market Share by Country (2027-2032) Table 61. Global Propofol Emulsion Injection Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Propofol Emulsion Injection Sales Value Market Share by Country (2021-2026) Table 63. Global Propofol Emulsion Injection Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Propofol Emulsion Injection Sales Value Market Share by Country (2027-2032) Table 65. Xian Libang Pharmaceutical Company Information Table 66. Xian Libang Pharmaceutical Business Overview Table 67. Xian Libang Pharmaceutical Propofol Emulsion Injection Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Xian Libang Pharmaceutical Propofol Emulsion Injection Product Portfolio Table 69. Xian Libang Pharmaceutical Recent Development Table 70. Teva Company Information Table 71. Teva Business Overview Table 72. Teva Propofol Emulsion Injection Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Teva Propofol Emulsion Injection Product Portfolio Table 74. Teva Recent Development Table 75. Sandoz Company Information Table 76. Sandoz Business Overview Table 77. Sandoz Propofol Emulsion Injection Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Sandoz Propofol Emulsion Injection Product Portfolio Table 79. Sandoz Recent Development Table 80. Jiangsu Nhwa Group Company Information Table 81. Jiangsu Nhwa Group Business Overview Table 82. Jiangsu Nhwa Group Propofol Emulsion Injection Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Jiangsu Nhwa Group Propofol Emulsion Injection Product Portfolio Table 84. Jiangsu Nhwa Group Recent Development Table 85. Pfizer Company Information Table 86. Pfizer Business Overview Table 87. Pfizer Propofol Emulsion Injection Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Pfizer Propofol Emulsion Injection Product Portfolio Table 89. Pfizer Recent Development Table 90. Sinopharm Guorui Pharm Company Information Table 91. Sinopharm Guorui Pharm Business Overview Table 92. Sinopharm Guorui Pharm Propofol Emulsion Injection Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Sinopharm Guorui Pharm Propofol Emulsion Injection Product Portfolio Table 94. Sinopharm Guorui Pharm Recent Development Table 95. Guangdong Jiabo Pharmaceutical Company Information Table 96. Guangdong Jiabo Pharmaceutical Business Overview Table 97. Guangdong Jiabo Pharmaceutical Propofol Emulsion Injection Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Guangdong Jiabo Pharmaceutical Propofol Emulsion Injection Product Portfolio Table 99. Guangdong Jiabo Pharmaceutical Recent Development Table 100. Fresenius Kabi Company Information Table 101. Fresenius Kabi Business Overview Table 102. Fresenius Kabi Propofol Emulsion Injection Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Fresenius Kabi Propofol Emulsion Injection Product Portfolio Table 104. Fresenius Kabi Recent Development Table 105. Baxter Company Information Table 106. Baxter Business Overview Table 107. Baxter Propofol Emulsion Injection Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Baxter Propofol Emulsion Injection Product Portfolio Table 109. Baxter Recent Development Table 110. AstraZeneca Company Information Table 111. AstraZeneca Business Overview Table 112. AstraZeneca Propofol Emulsion Injection Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. AstraZeneca Propofol Emulsion Injection Product Portfolio Table 114. AstraZeneca Recent Development Table 115. Sagent Company Information Table 116. Sagent Business Overview Table 117. Sagent Propofol Emulsion Injection Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. Sagent Propofol Emulsion Injection Product Portfolio Table 119. Sagent Recent Development Table 120. Dr. Reddy's Company Information Table 121. Dr. Reddy's Business Overview Table 122. Dr. Reddy's Propofol Emulsion Injection Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. Dr. Reddy's Propofol Emulsion Injection Product Portfolio Table 124. Dr. Reddy's Recent Development Table 125. B Braun Company Information Table 126. B Braun Business Overview Table 127. B Braun Propofol Emulsion Injection Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 128. B Braun Propofol Emulsion Injection Product Portfolio Table 129. B Braun Recent Development Table 130. Key Raw Materials Table 131. Raw Materials Key Suppliers Table 132. Propofol Emulsion Injection Distributors List Table 133. Propofol Emulsion Injection Customers List Table 134. Research Programs/Design for This Report Table 135. Authors List of This Report Table 136. Secondary Sources Table 137. Primary Sources List of Figures Figure 1. Propofol Emulsion Injection Product Image Figure 2. Global Propofol Emulsion Injection Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Propofol Emulsion Injection Sales Value (2021-2032) & (US$ Million) Figure 4. Global Propofol Emulsion Injection Sales (2021-2032) & (W Units) Figure 5. Global Propofol Emulsion Injection Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Propofol Emulsion Injection Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 20ml/vial Image Figure 10. 50ml/vial Image Figure 11. 100ml/vial Image Figure 12. Global Propofol Emulsion Injection Sales Volume by Type (2021 VS 2025 VS 2032) & (W Units) Figure 13. Global Propofol Emulsion Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Propofol Emulsion Injection Sales Volume Share by Type (2021-2032) Figure 15. Global Propofol Emulsion Injection Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Propofol Emulsion Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Propofol Emulsion Injection Sales Value Share by Type (2021-2032) Figure 18. Hospital Image Figure 19. Clinics Image Figure 20. Recovery Center Image Figure 21. Global Propofol Emulsion Injection Sales Volume by Application (2021 VS 2025 VS 2032) & (W Units) Figure 22. Global Propofol Emulsion Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Propofol Emulsion Injection Sales Volume Share by Application (2021-2032) Figure 24. Global Propofol Emulsion Injection Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Propofol Emulsion Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Propofol Emulsion Injection Sales Value Share by Application (2021-2032) Figure 27. Global Propofol Emulsion Injection Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 28. Global Propofol Emulsion Injection Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Propofol Emulsion Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Propofol Emulsion Injection Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Propofol Emulsion Injection Sales Value (2021-2032) & (US$ Million) Figure 32. North America Propofol Emulsion Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Propofol Emulsion Injection Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Propofol Emulsion Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Propofol Emulsion Injection Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Propofol Emulsion Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Propofol Emulsion Injection Sales Value (2021-2032) & (US$ Million) Figure 38. South America Propofol Emulsion Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Propofol Emulsion Injection Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Propofol Emulsion Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Propofol Emulsion Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Propofol Emulsion Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Propofol Emulsion Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Propofol Emulsion Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Propofol Emulsion Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Propofol Emulsion Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Propofol Emulsion Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Propofol Emulsion Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Propofol Emulsion Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Propofol Emulsion Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Propofol Emulsion Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Propofol Emulsion Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Propofol Emulsion Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Propofol Emulsion Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Propofol Emulsion Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Propofol Emulsion Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Propofol Emulsion Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Propofol Emulsion Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Propofol Emulsion Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Propofol Emulsion Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Propofol Emulsion Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Propofol Emulsion Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Propofol Emulsion Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Propofol Emulsion Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Propofol Emulsion Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Propofol Emulsion Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Propofol Emulsion Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Propofol Emulsion Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Propofol Emulsion Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Propofol Emulsion Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Propofol Emulsion Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Propofol Emulsion Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Propofol Emulsion Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Propofol Emulsion Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Propofol Emulsion Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Propofol Emulsion Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Propofol Emulsion Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Propofol Emulsion Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Propofol Emulsion Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Propofol Emulsion Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Propofol Emulsion Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Propofol Emulsion Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Propofol Emulsion Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Propofol Emulsion Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Propofol Emulsion Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Propofol Emulsion Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Propofol Emulsion Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Propofol Emulsion Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Propofol Emulsion Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Propofol Emulsion Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Propofol Emulsion Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Propofol Emulsion Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Propofol Emulsion Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Propofol Emulsion Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Propofol Emulsion Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Propofol Emulsion Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Propofol Emulsion Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Propofol Emulsion Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Propofol Emulsion Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Propofol Emulsion Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Propofol Emulsion Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Propofol Emulsion Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Propofol Emulsion Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Propofol Emulsion Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Propofol Emulsion Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Propofol Emulsion Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Propofol Emulsion Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Propofol Emulsion Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Propofol Emulsion Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Propofol Emulsion Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Propofol Emulsion Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Propofol Emulsion Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Propofol Emulsion Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Propofol Emulsion Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Propofol Emulsion Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Propofol Emulsion Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Propofol Emulsion Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Propofol Emulsion Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Propofol Emulsion Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Propofol Emulsion Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Propofol Emulsion Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Propofol Emulsion Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Propofol Emulsion Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Propofol Emulsion Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Propofol Emulsion Injection Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Propofol Emulsion Injection Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • 20ml/vial
  • 50ml/vial
  • 100ml/vial
Applications
  • Hospital
  • Clinics
  • Recovery Center
Companies covered
  • Xian Libang Pharmaceutical
  • Teva
  • Sandoz
  • Jiangsu Nhwa Group
  • Pfizer
  • Sinopharm Guorui Pharm
  • Guangdong Jiabo Pharmaceutical
  • Fresenius Kabi
  • Baxter
  • AstraZeneca
  • Sagent
  • Dr. Reddy's
  • B Braun

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Propofol Emulsion Injection Sales Value (2021-2032)
  4. 1.2.2 Global Propofol Emulsion Injection Sales Volume (2021-2032)
  5. 1.2.3 Global Propofol Emulsion Injection Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Propofol Emulsion Injection Market Dynamics
  1. 2.1 Propofol Emulsion Injection Industry Trends
  2. 2.2 Propofol Emulsion Injection Industry Drivers
  3. 2.3 Propofol Emulsion Injection Industry Opportunities and Challenges
  4. 2.4 Propofol Emulsion Injection Industry Restraints
3 Propofol Emulsion Injection Market by Company
  1. 3.1 Global Propofol Emulsion Injection Company Revenue Ranking in 2025
  2. 3.2 Global Propofol Emulsion Injection Revenue by Company (2021-2026)
  3. 3.3 Global Propofol Emulsion Injection Sales Volume by Company (2021-2026)
  4. 3.4 Global Propofol Emulsion Injection Average Price by Company (2021-2026)
  5. 3.5 Global Propofol Emulsion Injection Company Ranking (2024-2026)
  6. 3.6 Global Propofol Emulsion Injection Company Manufacturing Base and Headquarters
  7. 3.7 Global Propofol Emulsion Injection Company Product Type and Application
  8. 3.8 Global Propofol Emulsion Injection Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Propofol Emulsion Injection Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Propofol Emulsion Injection Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Propofol Emulsion Injection Market by Type
  1. 4.1 Propofol Emulsion Injection Type Introduction
  2. 4.1.1 20ml/vial
  3. 4.1.2 50ml/vial
  4. 4.1.3 100ml/vial
  5. 4.2 Global Propofol Emulsion Injection Sales Volume by Type
  6. 4.2.1 Global Propofol Emulsion Injection Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Propofol Emulsion Injection Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Propofol Emulsion Injection Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Propofol Emulsion Injection Sales Value by Type
  10. 4.3.1 Global Propofol Emulsion Injection Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Propofol Emulsion Injection Sales Value by Type (2021-2032)
  12. 4.3.3 Global Propofol Emulsion Injection Sales Value Share by Type (2021-2032)
5 Propofol Emulsion Injection Market by Application
  1. 5.1 Propofol Emulsion Injection Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinics
  4. 5.1.3 Recovery Center
  5. 5.2 Global Propofol Emulsion Injection Sales Volume by Application
  6. 5.2.1 Global Propofol Emulsion Injection Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Propofol Emulsion Injection Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Propofol Emulsion Injection Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Propofol Emulsion Injection Sales Value by Application
  10. 5.3.1 Global Propofol Emulsion Injection Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Propofol Emulsion Injection Sales Value by Application (2021-2032)
  12. 5.3.3 Global Propofol Emulsion Injection Sales Value Share by Application (2021-2032)
6 Propofol Emulsion Injection Regional Sales and Value Analysis
  1. 6.1 Global Propofol Emulsion Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Propofol Emulsion Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Propofol Emulsion Injection Sales by Region: 2021-2026
  4. 6.2.2 Global Propofol Emulsion Injection Sales by Region (2027-2032)
  5. 6.3 Global Propofol Emulsion Injection Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Propofol Emulsion Injection Sales Value by Region (2021-2032)
  7. 6.4.1 Global Propofol Emulsion Injection Sales Value by Region: 2021-2026
  8. 6.4.2 Global Propofol Emulsion Injection Sales Value by Region (2027-2032)
  9. 6.5 Global Propofol Emulsion Injection Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Propofol Emulsion Injection Sales Value (2021-2032)
  12. 6.6.2 North America Propofol Emulsion Injection Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Propofol Emulsion Injection Sales Value (2021-2032)
  15. 6.7.2 Europe Propofol Emulsion Injection Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Propofol Emulsion Injection Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Propofol Emulsion Injection Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Propofol Emulsion Injection Sales Value (2021-2032)
  21. 6.9.2 South America Propofol Emulsion Injection Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Propofol Emulsion Injection Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Propofol Emulsion Injection Sales Value Share by Country, 2025 VS 2032
7 Propofol Emulsion Injection Country-level Sales and Value Analysis
  1. 7.1 Global Propofol Emulsion Injection Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Propofol Emulsion Injection Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Propofol Emulsion Injection Sales by Country (2021-2032)
  4. 7.3.1 Global Propofol Emulsion Injection Sales by Country (2021-2026)
  5. 7.3.2 Global Propofol Emulsion Injection Sales by Country (2027-2032)
  6. 7.4 Global Propofol Emulsion Injection Sales Value by Country (2021-2032)
  7. 7.4.1 Global Propofol Emulsion Injection Sales Value by Country (2021-2026)
  8. 7.4.2 Global Propofol Emulsion Injection Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Propofol Emulsion Injection Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Propofol Emulsion Injection Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Propofol Emulsion Injection Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Propofol Emulsion Injection Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Propofol Emulsion Injection Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Propofol Emulsion Injection Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Propofol Emulsion Injection Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Propofol Emulsion Injection Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Propofol Emulsion Injection Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Propofol Emulsion Injection Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Propofol Emulsion Injection Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Propofol Emulsion Injection Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Propofol Emulsion Injection Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Propofol Emulsion Injection Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Propofol Emulsion Injection Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Propofol Emulsion Injection Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Propofol Emulsion Injection Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Propofol Emulsion Injection Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Propofol Emulsion Injection Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Propofol Emulsion Injection Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Propofol Emulsion Injection Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Propofol Emulsion Injection Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Propofol Emulsion Injection Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Propofol Emulsion Injection Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Propofol Emulsion Injection Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Propofol Emulsion Injection Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Propofol Emulsion Injection Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Propofol Emulsion Injection Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Propofol Emulsion Injection Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Propofol Emulsion Injection Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Propofol Emulsion Injection Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Propofol Emulsion Injection Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Propofol Emulsion Injection Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Propofol Emulsion Injection Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Propofol Emulsion Injection Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Propofol Emulsion Injection Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Propofol Emulsion Injection Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Propofol Emulsion Injection Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Propofol Emulsion Injection Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Propofol Emulsion Injection Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Propofol Emulsion Injection Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Propofol Emulsion Injection Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Propofol Emulsion Injection Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Propofol Emulsion Injection Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Propofol Emulsion Injection Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Propofol Emulsion Injection Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Propofol Emulsion Injection Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Propofol Emulsion Injection Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Propofol Emulsion Injection Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Propofol Emulsion Injection Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Propofol Emulsion Injection Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Propofol Emulsion Injection Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Propofol Emulsion Injection Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Propofol Emulsion Injection Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Propofol Emulsion Injection Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Propofol Emulsion Injection Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Propofol Emulsion Injection Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Propofol Emulsion Injection Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Propofol Emulsion Injection Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Propofol Emulsion Injection Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Propofol Emulsion Injection Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Propofol Emulsion Injection Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Propofol Emulsion Injection Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Propofol Emulsion Injection Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Propofol Emulsion Injection Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Propofol Emulsion Injection Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Propofol Emulsion Injection Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Propofol Emulsion Injection Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Propofol Emulsion Injection Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Propofol Emulsion Injection Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Propofol Emulsion Injection Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Propofol Emulsion Injection Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Propofol Emulsion Injection Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Propofol Emulsion Injection Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Propofol Emulsion Injection Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Propofol Emulsion Injection Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Propofol Emulsion Injection Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Propofol Emulsion Injection Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Propofol Emulsion Injection Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Propofol Emulsion Injection Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Propofol Emulsion Injection Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Propofol Emulsion Injection Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Propofol Emulsion Injection Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Propofol Emulsion Injection Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Xian Libang Pharmaceutical
  2. 8.1.1 Xian Libang Pharmaceutical Company Information
  3. 8.1.2 Xian Libang Pharmaceutical Business Overview
  4. 8.1.3 Xian Libang Pharmaceutical Propofol Emulsion Injection Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Xian Libang Pharmaceutical Propofol Emulsion Injection Product Portfolio
  6. 8.1.5 Xian Libang Pharmaceutical Recent Developments
  7. 8.2 Teva
  8. 8.2.1 Teva Company Information
  9. 8.2.2 Teva Business Overview
  10. 8.2.3 Teva Propofol Emulsion Injection Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Teva Propofol Emulsion Injection Product Portfolio
  12. 8.2.5 Teva Recent Developments
  13. 8.3 Sandoz
  14. 8.3.1 Sandoz Company Information
  15. 8.3.2 Sandoz Business Overview
  16. 8.3.3 Sandoz Propofol Emulsion Injection Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Sandoz Propofol Emulsion Injection Product Portfolio
  18. 8.3.5 Sandoz Recent Developments
  19. 8.4 Jiangsu Nhwa Group
  20. 8.4.1 Jiangsu Nhwa Group Company Information
  21. 8.4.2 Jiangsu Nhwa Group Business Overview
  22. 8.4.3 Jiangsu Nhwa Group Propofol Emulsion Injection Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Jiangsu Nhwa Group Propofol Emulsion Injection Product Portfolio
  24. 8.4.5 Jiangsu Nhwa Group Recent Developments
  25. 8.5 Pfizer
  26. 8.5.1 Pfizer Company Information
  27. 8.5.2 Pfizer Business Overview
  28. 8.5.3 Pfizer Propofol Emulsion Injection Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Pfizer Propofol Emulsion Injection Product Portfolio
  30. 8.5.5 Pfizer Recent Developments
  31. 8.6 Sinopharm Guorui Pharm
  32. 8.6.1 Sinopharm Guorui Pharm Company Information
  33. 8.6.2 Sinopharm Guorui Pharm Business Overview
  34. 8.6.3 Sinopharm Guorui Pharm Propofol Emulsion Injection Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Sinopharm Guorui Pharm Propofol Emulsion Injection Product Portfolio
  36. 8.6.5 Sinopharm Guorui Pharm Recent Developments
  37. 8.7 Guangdong Jiabo Pharmaceutical
  38. 8.7.1 Guangdong Jiabo Pharmaceutical Company Information
  39. 8.7.2 Guangdong Jiabo Pharmaceutical Business Overview
  40. 8.7.3 Guangdong Jiabo Pharmaceutical Propofol Emulsion Injection Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Guangdong Jiabo Pharmaceutical Propofol Emulsion Injection Product Portfolio
  42. 8.7.5 Guangdong Jiabo Pharmaceutical Recent Developments
  43. 8.8 Fresenius Kabi
  44. 8.8.1 Fresenius Kabi Company Information
  45. 8.8.2 Fresenius Kabi Business Overview
  46. 8.8.3 Fresenius Kabi Propofol Emulsion Injection Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Fresenius Kabi Propofol Emulsion Injection Product Portfolio
  48. 8.8.5 Fresenius Kabi Recent Developments
  49. 8.9 Baxter
  50. 8.9.1 Baxter Company Information
  51. 8.9.2 Baxter Business Overview
  52. 8.9.3 Baxter Propofol Emulsion Injection Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Baxter Propofol Emulsion Injection Product Portfolio
  54. 8.9.5 Baxter Recent Developments
  55. 8.10 AstraZeneca
  56. 8.10.1 AstraZeneca Company Information
  57. 8.10.2 AstraZeneca Business Overview
  58. 8.10.3 AstraZeneca Propofol Emulsion Injection Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 AstraZeneca Propofol Emulsion Injection Product Portfolio
  60. 8.10.5 AstraZeneca Recent Developments
  61. 8.11 Sagent
  62. 8.11.1 Sagent Company Information
  63. 8.11.2 Sagent Business Overview
  64. 8.11.3 Sagent Propofol Emulsion Injection Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Sagent Propofol Emulsion Injection Product Portfolio
  66. 8.11.5 Sagent Recent Developments
  67. 8.12 Dr. Reddy's
  68. 8.12.1 Dr. Reddy's Company Information
  69. 8.12.2 Dr. Reddy's Business Overview
  70. 8.12.3 Dr. Reddy's Propofol Emulsion Injection Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Dr. Reddy's Propofol Emulsion Injection Product Portfolio
  72. 8.12.5 Dr. Reddy's Recent Developments
  73. 8.13 B Braun
  74. 8.13.1 B Braun Company Information
  75. 8.13.2 B Braun Business Overview
  76. 8.13.3 B Braun Propofol Emulsion Injection Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 B Braun Propofol Emulsion Injection Product Portfolio
  78. 8.13.5 B Braun Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Propofol Emulsion Injection Value Chain Analysis
  2. 9.1.1 Propofol Emulsion Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Propofol Emulsion Injection Sales Mode & Process
  6. 9.2 Propofol Emulsion Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Propofol Emulsion Injection Distributors
  9. 9.2.3 Propofol Emulsion Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst